(LLY) Eli Lilly - Performance -14.7% in 12m
LLY performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
63.05%
#11 in Peer-Group
Rel. Strength
25.14%
#5762 in Stock-Universe
Total Return 12m
-14.71%
#125 in Peer-Group
Total Return 5y
404.71%
#4 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 63.7 |
| P/E Forward | 35.8 |
| High / Low | USD |
|---|---|
| 52 Week High | 954.83 USD |
| 52 Week Low | 713.71 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 45.69 |
| Buy/Sell Signal +-5 | 0.18 |
| Support / Resistance | Levels |
|---|---|
| Support | 771.6, 718.5 |
| Resistance | 930.7, 896.9, 872.8, 824.6, 795.7 |
12m Total Return: LLY (-14.7%) vs XLV (-4.8%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-3.42% | 131% | 313% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
3.1% | 16.7% | 81% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
0.51% | -14.7% | 405% | 63.7 | 35.8 | 1.2 | 58.2% | 18.9% |
| NOVN SW Novartis |
0.14% | 4.1% | 53.5% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-5.82% | 3.79% | 51.6% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-8.26% | -8.24% | 110% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-4.1% | -7.38% | 46.1% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| UCB BR UCB |
5.98% | 19.9% | 66.1% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: LLY vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for LLY
| Total Return (including Dividends) | LLY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 0.51% | 1.09% | 3.75% |
| 3 Months | 7.30% | 1.98% | 25.32% |
| 12 Months | -14.71% | -4.84% | 13.11% |
| 5 Years | 404.71% | 45.05% | 109.78% |
| Trend Score (consistency of price movement) | LLY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -27.3% | 20.4% | 80.3% |
| 3 Months | 11.3% | -22.1% | 97.2% |
| 12 Months | -56.4% | -76.5% | 45.4% |
| 5 Years | 97.2% | 87.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th53.00 | -0.57% | -3.12% |
| 3 Month | %th35.00 | 5.22% | -14.38% |
| 12 Month | %th38.00 | -10.37% | -24.59% |
| 5 Years | %th98.00 | 247.96% | 140.59% |
FAQs
Does Eli Lilly (LLY) outperform the market?
No,
over the last 12 months LLY made -14.71%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.84%.
Over the last 3 months LLY made 7.30%, while XLV made 1.98%.
Performance Comparison LLY vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
LLY vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.2% | -3.2% | -6.7% | -28% |
| US NASDAQ 100 | QQQ | -0.8% | -3.7% | -8.3% | -26% |
| German DAX 40 | DAX | -2.1% | 0.3% | -19.5% | -45% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.3% | -3.2% | -10.4% | -36% |
| Hongkong Hang Seng | HSI | 0.2% | -2.5% | -27.2% | -54% |
| India NIFTY 50 | INDA | 0.5% | -0.3% | -7.3% | -14% |
| Brasil Bovespa | EWZ | 0.5% | -5.4% | -28.7% | -22% |
LLY vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.1% | -3% | -11.2% | -39% |
| Consumer Discretionary | XLY | 0.5% | -1.5% | 1.1% | -31% |
| Consumer Staples | XLP | 1% | 0.1% | -7.3% | -23% |
| Energy | XLE | -3.3% | -6.3% | -3% | -17% |
| Financial | XLF | 1.1% | -2.2% | -9.3% | -43% |
| Health Care | XLV | 1.5% | -0.6% | 2.2% | -10% |
| Industrial | XLI | -0.3% | -2.6% | -13.6% | -39% |
| Materials | XLB | -1.1% | -3.3% | -10.3% | -20% |
| Real Estate | XLRE | 0.9% | 0.7% | -5.6% | -26% |
| Technology | XLK | -1.9% | -6.7% | -10.8% | -25% |
| Utilities | XLU | 1.2% | -0.8% | -9.1% | -36% |
| Aerospace & Defense | XAR | -0.9% | -3.3% | -24.9% | -63% |
| Biotech | XBI | -1.7% | -0% | 7.4% | -6% |
| Homebuilder | XHB | 1.1% | -5.5% | 1.2% | -18% |
| Retail | XRT | -0.3% | -1% | -2% | -25% |
LLY vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -3.9% | -6.30% | -0.40% | -10% |
| Natural Gas | UNG | 2.1% | 11% | 12.5% | -8% |
| Gold | GLD | 1.3% | 1.3% | -24.6% | -54% |
| Silver | SLV | -1.5% | 0.8% | -22.3% | -33% |
| Copper | CPER | -6.7% | -9.6% | -27.1% | -33% |
LLY vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 2.6% | -0.6% | -3% | -11% |
| iShares High Yield Corp. Bond | HYG | 0.5% | -0.8% | -5.1% | -24% |